Keywords: sanofi-synthelabo, remains, confident, aventis, buy, reports, strong
Sanofi-Synthelabo remains confident on Aventis buy; reports strong financials
Article | 23 February 2004
Jean-Francois Dehecq, chief executive of French drug major Sanofi-Synthelabo, has reiterated his strong conviction that his unsolicited takeover bid for ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- New study shows UCB's Neupro reduces NSBP in RLS patient
